1-4 of 4
Lasika Seneviratne
Close
Sort by
Journal Articles

A Phase 1b Study Investigating Carfilzomib Administered Once Weekly in Combination with Lenalidomide and Dexamethasone in Patients with Multiple Myeloma

Noa Biran, David S. Siegel, MD PhD, Jesus G. Berdeja, MD, Edward Faber, Lasika Seneviratne, Melissa Alsina, William Bensinger, Amy S. Kimball, Kefei Zhou, Ola Landgren, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3322.
https://doi.org/10.1182/blood.V128.22.3322.3322
Published: 2016
Journal Articles

An Expanded Treatment Protocol of Panobinostat Plus Bortezomib and Dexamethasone in Patients with Previously Treated Myeloma

Vincent L Hansen, MD, Morton Coleman, MD, Stephanie Elkins, MD, Jeffrey P. Letzer, Moshe Yair Levy, MD, Lasika Seneviratne, MD, Jessica Rine, Marina White, Emil T Kuriakose, MD
Journal: Blood
Blood (2015) 126 (23): 3027.
https://doi.org/10.1182/blood.V126.23.3027.3027
Published: 2015
Journal Articles

Clinical, immunologic, and pathologic correlates of bone marrow involvement in 291 patients with acquired immunodeficiency syndrome–related lymphoma

Clinical Trials & Observations
Lasika Seneviratne, Byron M. Espina, Bharat N. Nathwani, Joel A. Chan, Russell K. Brynes, Alexandra M. Levine
Journal: Blood
Blood (2001) 98 (8): 2358–2363.
https://doi.org/10.1182/blood.V98.8.2358
Published: 2001
Journal Articles

Evolving characteristics of AIDS-related lymphoma

Clinical Trials & Observations
Alexandra M. Levine, Lasika Seneviratne, Byron M. Espina, Amy Rock Wohl, Anil Tulpule, Bharat N. Nathwani, Parkash S. Gill
Journal: Blood
Blood (2000) 96 (13): 4084–4090.
https://doi.org/10.1182/blood.V96.13.4084
Published: 2000